Minor Stroke
8
2
2
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
38%
3 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (8)
Butylphthalide for Long-term Efficacy in Minor Stroke Study
Stroke School -Including Physical Exercise, Patient Education and Individual Follow-up Sessions
Early-phase Telecare Programs for Minor Stroke
Non-disabling Ischemic Cerebrovascular Event With Apathy
Thrombolysis of Urokinase for Minor Stroke
Multiple Interventions to Accelerate the Return to the Pre-event Level of Functioning After a TIA and Minor Stroke
The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack
China Registry of Non-disabling Ischemic Cerebrovascular Events